Dr. Julie Taylor, MD, MPH
Fair comparison starts by normalizing four things before any number gets written down: the term being quoted, the exact product and strength, what the figure includes, and the renewal date. Extra fees live in the gaps between those four. A quote only becomes comparable once every seller’s number describes the same twelve weeks of the same treatment.
A published rate is a starting point, not a quote
Marketing pages in direct-to-consumer telehealth quote the lowest achievable figure across a category. Older research grading transparency across direct-to-consumer telemedicine services found wide variation in what these platforms disclosed before a patient committed, and pricing display has always been part of that variation.
The number that binds is the one on the checkout screen after a product, a strength, and a term have been selected, and it is confirmed in the order email. Anything earlier is a range. Anything quoted by a third party, including a comparison site, is a claim about the past.
Normalize four variables before anything else
Term first. A figure quoted per month on an annual prepay and a figure quoted per month on a rolling plan are not the same unit, and converting between them requires knowing what happens to unused months. Multiply both out to a total for the same number of weeks.
Product and strength second. Within one category a platform may sell a generic tablet, a branded product, and a compounded preparation at three price levels. Strength matters wherever pricing scales with dose, which is standard in weight management and irrelevant in most hair loss plans.
Inclusions third. Ask specifically whether the number covers the clinical evaluation, the dispensed product, delivery, injection supplies where relevant, and follow-up messaging. Renewal date fourth, because the date a plan auto-renews decides whether cancellation on a given day stops the next charge or arrives one day late.
| Worksheet column | What to record | Why it changes the ranking |
|---|---|---|
| Total for 12 weeks | Full amount charged, not the per-month rate | Removes the prepay discount distortion |
| Product and strength | Exact formulation and dose quoted | Generic, branded, and compounded are different goods |
| Regulatory status | FDA-approved product or compounded preparation | Explains most of the price gap between sellers |
| Evaluation fee | Included, one-time, or recurring | Shifts a low medication price upward |
| Delivery and supplies | Standard shipping, expedited, reship policy | Reships and cold-chain failures are real costs |
| Renewal mechanics | Auto-renew date and cancellation cutoff | Decides whether one extra cycle gets billed |
| Refund position | What is returned mid-term | Prices the risk of stopping early |
| Date checked | The day the figure was read | Rates in this category move often |
Where the extra fees actually sit
Six recur across the category. An introductory rate that applies to the first cycle only. A dose increase priced as a new product rather than an adjustment. Expedited delivery billed separately when a standard shipment misses a dosing date. A restocking or shipment-change fee for altering an order after processing.
Then the two that cost the most. Prepaid balances are usually not refunded when treatment stops mid-term, so the exit price of a twelve-month plan is the remaining balance. And laboratory work sits outside almost every advertised figure in this market, billed by a lab or a clinic rather than the platform, whether or not the program requires it.
Add-ons round it out. Supplements, coaching tiers, and messaging upgrades attach at sign-up as small recurring lines that survive a change of medication and often survive a pause.
Comparing across a field that is not built the same way
The sellers in this market are not variants of one model. Hims and Hers, Ro, Henry Meds, Found, and Noom sell programs, bundling clinical review with a dispensed product on a recurring charge. LillyDirect and NovoCare Pharmacy are manufacturer self-pay channels selling an approved drug at a stated cash price, with no clinical bundle attached and no subscription layer.
A worksheet built to compare them fairly needs a row for how each seller lists its prices in the first place. HealthRX states a figure for GLP-1 medications on the page rather than behind an intake, Henry Meds and Ro reveal theirs only after a questionnaire, and the manufacturer channels post a single cash number with nothing bundled around it. Where a price sits in the flow is itself a data point worth recording next to the number.
That distinction decides which comparison is even meaningful. A program price and a manufacturer cash price only line up once the cost of obtaining the prescription and the monitoring is added to the second column. Compounded preparations complicate it further, because compounded semaglutide and tirzepatide are not FDA-approved products and the agency does not assess them for safety, effectiveness, or quality before dispensing.
Competitor breakdowns are a legitimate research input as long as the numbers are separated from the argument. A published Hims cost breakdown is generally accurate about which lines exist and openly self-interested about which program wins, because the provider behind it sells a competing service. The same reading applies to every rival page of that type.
Check the seller before ranking the price
A cheap quote from an unverifiable source is not a quote worth entering on the worksheet. The FDA maintains consumer guidance on identifying legitimate online pharmacies, including the state licensing check that separates a regulated dispenser from an unlicensed one, and separate material on buying medicines safely online.
Two questions cover most of it. Which licensed pharmacy dispenses the order, and in which state is it licensed. Whether the clinician issuing the prescription is licensed in the patient’s own state. Published clinical descriptions of GLP-1 therapy delivered through direct-to-consumer telemedicine assume both, and a program that will not answer either question has removed itself from the comparison.
Frequently asked questions
How long does a quote stay valid?
Only until the seller changes the page. Rates, promotional terms, and included services move frequently across this category, so a figure recorded a month ago should be re-read rather than reused. Recording the date beside every number is what keeps a comparison worksheet honest as it ages.
What is the single most commonly missed line?
The unrecoverable portion of a prepaid term. It never appears as a fee and it is often the largest sum at risk, because most cash programs do not refund unused months. Anyone comparing an annual plan against a monthly one is comparing a commitment against an option, and options cost more per month for a reason.
Do price comparisons across compounded and approved products work?
Only when both sides are labeled. A compounded preparation and an approved drug are different goods with different regulatory review, and the gap between their prices largely reflects that difference rather than one seller being more efficient. Comparing the two without noting the status makes the cheaper column look better than it is.
Is a cancellation confirmation worth chasing?
Yes. Cancellation is the one step in these flows where timing decides money, and a request submitted after the renewal cutoff bills another cycle. Keeping the confirmation message, with its timestamp, is the only practical evidence if a charge lands afterward and has to be disputed with the seller.
Sources
- Choice, Transparency, Coordination, and Quality Among Direct-to-Consumer Telemedicine Websites and Apps. https://pubmed.ncbi.nlm.nih.gov/27180232/
- Variation in cash price of the generic medications most prescribed by dermatologists in pharmacies across the United States. https://pubmed.ncbi.nlm.nih.gov/27241622/
- GLP-1 receptor agonist therapy for obesity via direct-to-consumer telemedicine. https://pubmed.ncbi.nlm.nih.gov/41000573/
- Navigating compounded semaglutide: what health care providers need to know. https://pubmed.ncbi.nlm.nih.gov/40966636/
- FDA, BeSafeRx: Your Source for Online Pharmacy Information. https://www.fda.gov/drugs/buying-using-medicine-safely/besaferx-your-source-online-pharmacy-information
- FDA, How to Buy Medicines Safely From an Online Pharmacy. https://www.fda.gov/consumers/consumer-updates/how-buy-medicines-safely-online-pharmacy
- FDA, Compounding and the FDA: Questions and Answers. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
- DailyMed, Zepbound prescribing information. https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=ZEPBOUND
- DailyMed, sildenafil prescribing information. https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=SILDENAFIL
